13 years đŸ¥³ of Publication, 100k+ Stories, 30+ Countries
Search
The Latest News from All Areas of Deals
Latham & Watkins Advises Revolution Medicines in Upsized US$750 Million Public Offering of Common Stock and Pre-Funded Warrants
Firm represents the clinical-stage oncology company in the transaction. Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted…
Latham Advises on IREN Limited’s Upsized US$400 Million Convertible Senior Notes Offering
Multidisciplinary advises on the offering by the data center business powering the future of Bitcoin, AI, and beyond utilizing 100%…
Latham & Watkins Advises Worthington Steel on Acquisition of Sitem Group
Latham & Watkins advised Worthington Steel, Inc., on the acquisition, through its subsidiary, Tempel Steel Company, LLC, of a controlling…
Latham & Watkins Advises Coherus BioSciences in US$558.4 Million Divesture of UDENYCA Franchise to Intas Pharmaceuticals
Multidisciplinary team represents the biopharmaceutical company in the transaction. Coherus BioSciences, Inc. (NASDAQ: CHRS) announced that it has entered into…
Weil Advises Blackstone in Preferred Equity Investment in Inhabit
Weil is advising Blackstone Tactical Opportunities in its preferred equity investment in Inhabit, a global leader in property management software…
Weil Advises Astorg in $282M Take-Private Acquisition of Hamilton Thorne and Concurrent Acquisition of Cook Medical Reproductive Health
Weil advised Astorg, a leading private equity firm with an extensive track record in global healthcare investments, in its approximately…
